Funding for this research was provided by:
National Institute of General Medical Sciences (T32-GM081740)
National Institute of Environmental Health Sciences (R21ES014947, P01ES022831, R01ES016772)
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK085173)
U.S. Environmental Protection Agency (RD-83543701)
Office of Research on Women's Health (K12HD043446)
Text and Data Mining valid from 2019-08-07
Received: 17 May 2018
Accepted: 22 July 2019
First Online: 7 August 2019
Ethics approval and consent to participate
: The secondary analysis of the Newborn Epigentic Study data was reviewed, approved, and determined to be exempt by the North Carolina Central University Institutional Review Board. (Approval Numbers 1201403 and 1201306).
: Not applicable.
: The authors declare that they have no competing interests.